Xenium spatial platform
-
10x Genomics Partners with PharosAI to Build Breakthrough AI‑Ready Cancer Datasets
TXG performance by TradingView Strategic Partnership Announcement 10x Genomics, Inc. (Nasdaq: TXG) announced that PharosAI, a UK research consortium, will use its Xenium spatial platform to create one of the world’s most comprehensive multimodal cancer datasets. Backed by £18.9 million from the UK Government’s Research Ventures Catalyst and additional support from charities and industry partners,…
